Moderate impairment of renal function and cardiovascular risk;Altération modérée de la fonction rénale et risque cardiovasculaire

Revue de Medecine Interne

Volumn 30, Issue 7, 2009, Pages 585-591

  Fesler, P ^a   Ribstein, J ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Cardiovascular risk; Chronic kidney disease

Indexed keywords

ANEMIA; BLOOD VESSEL FUNCTION; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; MICROALBUMINURIA; PHOSPHATE METABOLISM; PREVALENCE; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SHORT SURVEY;

ALBUMINURIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; RISK;

EID: 67649391004     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.10.018     Document Type: Short Survey

References (55)

1. Stengel B., Billon S., Van Dijk P.C.W., Jager K.J., Dekker F.W., Simpson K., et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 18 (2003) 1824-1833
2. US Renal Data System: USRDS, 2003 Annual Data Report. Bethesda, MDm National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2003.
3. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
4. Manjunath G., Tighiouart H., Ibrahim H., MacLeod B., Salem D.N., Griffith J.L., et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41 (2003) 47-55
5. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
6. Weiner D.E., Tighiouart H., Stark P.C., Amin M.G., MacLeod B., Griffith J.L., et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 44 (2004) 198-206
7. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42 (2003) 1050-1065
8. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
9. Modification of Diet in Renal Disease Study Group, Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
10. Froissart M., Rossert J., Jacquot C., Paillard M., and Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16 (2005) 763-773
11. Verhave J.C., Fesler P., Ribstein J., du Cailar G., and Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 46 (2005) 233-241
12. Myers G.L., Miller W.G., Coresh J., Fleming J., Greenberg N., Greene T., et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52 (2006) 5-18
13. Hojs R., Bevc S., Ekart R., Gorenjak M., and Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 21 (2006) 1855-1862
14. White C., Akbari A., Hussain N., Dinh L., Filler G., Lepage N., et al. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 16 (2005) 3763-3770
15. Zahran A., Qureshi M., and Shoker A. Comparison between creatinine and cystatin C-based GFR equations in renal transplantation. Nephrol Dial Transplant 22 (2007) 2659-2668
16. Van Den Noortgate N.J., Janssens W.H., Delanghe J.R., Afschrift M.B., and Lameire N.H. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc 50 (2002) 1278-1282
17. Couchoud C., Pozet N., Labeeuw M., and Pouteil-Noble C. Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int 55 (1999) 1878-1884
18. Anaes. Diagnostic de l'insuffisance rénale chronique de l'adulte. 2002.
19. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
20. Foley R.N., Parfrey P.S., and Sarnak M.J. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9 (1998) S16-23
21. Tonelli M., Wiebe N., Culleton B., House A., Rabbat C., Fok M., et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17 (2006) 2034-2047
22. Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., Martin C.J., Murray D.C., et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47 (1995) 186-192
23. Culleton B.F., Larson M.G., Wilson P.W., Evans J.C., Parfrey P.S., and Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56 (1999) 2214-2219
24. Go A.S., Yang J., Ackerson L.M., Lepper K., Robbins S., Massie B.M., et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 113 (2006) 2713-2723
25. Shlipak M.G., Katz R., Sarnak M.J., Fried L.F., Newman A.B., Stehman-Breen C., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145 (2006) 237-246
26. Mann J.F., Gerstein H.C., Pogue J., Bosch J., and Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (2001) 629-636
27. Ibsen H., Wachtell K., Olsen M.H., Borch-Johnsen K., Lindholm L.H., Mogensen C.E., et al. Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. J Hypertens 22 (2004) 1805-1811
28. Borch-Johnsen K., Feldt-Rasmussen B., Strandgaard S., Schroll M., and Jensen J.S. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19 (1999) 1992-1997
29. Klausen K., Borch-Johnsen K., Feldt-Rasmussen B., Jensen G., Clausen P., Scharling H., et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110 (2004) 32-35
30. Jager A., Kostense P.J., Ruhé H.G., Heine R.J., Nijpels G., Dekker J.M., et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 19 (1999) 617-624
31. Roest M., Banga J.D., Janssen W.M., Grobbee D.E., Sixma J.J., de Jong P.E., et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 103 (2001) 3057-3061
32. The Nord-Trøndelag Health Study (HUNT), Norway, Romundstad S., Holmen J., Hallan H., Kvenild K., and Ellekjaer H. Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter?. Circulation 108 (2003) 2783-2789
33. The Nord-Trøndelag Health Study (HUNT), Norway, Romundstad S., Holmen J., Kvenild K., Hallan H., and Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. Am J Kidney Dis 42 (2003) 466-473
34. Verhave J.C., Hillege H.L., Burgerhof J.G.M., Gansevoort R.T., de Zeeuw D., and de Jong P.E. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 67 (2005) 1967-1973
35. Sarnak M.J., Coronado B.E., Greene T., Wang S.R., Kusek J.W., Beck G.J., et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 57 (2002) 327-335
36. Longenecker J.C., Coresh J., Powe N.R., Levey A.S., Fink N.E., Martin A., et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 13 (2002) 1918-1927
37. Muntner P., He J., Astor B.C., Folsom A.R., and Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol 16 (2005) 529-538
38. Doherty T.M., Tang W., Dascalos S., Watson K.E., Demer L.L., Shavelle R.M., et al. Ethnic origin and serum levels of 1alpha, 25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 96 (1997) 1477-1481
39. Kestenbaum B., Sampson J.N., Rudser K.D., Patterson D.J., Seliger S.L., Young B., et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16 (2005) 520-528
40. Pecoits-Filho R., Heimbürger O., Bárány P., Suliman M., Fehrman-Ekholm I., Lindholm B., et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41 (2003) 1212-1218
41. Koenig W., Sund M., Fröhlich M., Fischer H.G., Löwel H., Döring A., et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
42. Menon V., Greene T., Wang X., Pereira A.A., Marcovina S.M., Beck G.J., et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 68 (2005) 766-772
43. Mitchell G.F. Increased aortic stiffness: an unfavorable cardiorenal connection. Hypertension 43 (2004) 151-153
44. Safar M.E., London G.M., and Plante G.E. Arterial stiffness and kidney function. Hypertension 43 (2004) 163-168
45. Franklin S.S., Khan S.A., Wong N.D., Larson M.G., and Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation 100 (1999) 354-360
46. Alfie J., Waisman G.D., Galarza C.R., and Camera M.I. Contribution of stroke volume to the change in pulse pressure pattern with age. Hypertension 34 (1999) 808-812
47. Verhave J.C., Fesler P., du Cailar G., Ribstein J., Safar M.E., and Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension 45 (2005) 586-591
48. Fesler P., Safar M.E., du Cailar G., Ribstein J., and Mimran A. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J Hypertens 25 (2007) 1915-1920
49. Schillaci G., Pirro M., Mannarino M.R., Pucci G., Savarese G., Franklin S.S., et al. Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension 48 (2006) 616-621
50. Gosse P., and Safar M.E. Arterial stiffness and plasma creatinine in untreated hypertensive patients. Am J Hypertens 18 (2005) 1140-1145
51. Desbien A.M., Chonchol M., Gnahn H., and Sander D. Kidney function and progression of carotid intima-media thickness in a community study. Am J Kidney Dis 51 (2008) 584-593
52. Wilkinson I.B., Franklin S.S., and Cockcroft J.R. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 44 (2004) 112-116
53. Ito S., Arima S., Ren Y.L., Juncos L.A., and Carretero O.A. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 91 (1993) 2012-2019
54. Wever R., Boer P., Hijmering M., Stroes E., Verhaar M., Kastelein J., et al. Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 19 (1999) 1168-1172
55. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575